Target intelligence / Profile preview

RNA, U1 small nuclear 153, pseudogene (RNU1-153P)

Target
RNU1-153P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RNA, U1 small nuclear 153, pseudogene (RNU1-153P) is a genomic sequence that closely resembles the functional U1 small nuclear RNA gene but is classified as a pseudogene[1][4]. Pseudogenes are generally non-functional copies of genes, usually lacking the capacity to encode a functional product or to participate in biological processes[1][4]. This particular pseudogene is annotated in genomics databases but does not encode a protein or RNA that performs a defined function[1][4]. The canonical functional counterparts, such as U1 small nuclear RNA, play key roles in pre-mRNA splicing as part of the U1 small nuclear ribonucleoprotein (snRNP) complex[2][3]. These snRNAs bind at the 5' exon-intron junction of pre-mRNA, initiating spliceosome assembly and enabling splice site recognition[2][3]. However, RNU1-153P itself is not involved in splicing and carries no known biological activity or therapeutic target status[1][4]. - A pseudogene designation (such as RNU1-153P) typically means the locus is not transcribed into a functional RNA and/or lacks biological function. - There are no known disease associations, drug interactions, mechanism of action, biomarker roles, or safety concerns specifically reported for RNU1-153P[1][4]. Summary: RNU1-153P is not a receptor, enzyme, transporter, or any canonical therapeutic target but rather a genomic pseudogene related to the U1 snRNA gene family, with no reported functional, pharmacological, or biomarker relevance[1][4].

Other names
RNU1-153P

Beyond the preview

Go deeper on RNA, U1 small nuclear 153, pseudogene (RNU1-153P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 153, pseudogene (RNU1-153P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call